The Europe Union and drugmakers pledged on Thursday to invest 280 million euros ($350 million) in Ebola research, with the lion’s share going to the testing and manufacture of potential vaccines.
The Europe Union and drugmakers pledged on Thursday to invest 280 million euros ($350 million) in Ebola research, with the lion’s share going to the testing and manufacture of potential vaccines.